Double-blind cross-over study of ketoprofen and ibuprofen in management of rheumatoid arthritis

Br Med J. 1973 Oct 13;4(5884):82-4. doi: 10.1136/bmj.4.5884.82.

Abstract

A double-blind cross-over study of ketoprofen (Orudis) 150 mg daily and ibuprofen (Brufen) 1,200 mg daily was carried out in 35 outpatients with rheumatoid arthritis. Results suggest that analgesic and anti-inflammatory activity of ketoprofen is superior to that of ibuprofen. Significantly greater pain relief (P < 0.05) and reduction in joint circumference (P < 0.01) was obtained with ketoprofen than with ibuprofen. Side effects of the drugs were comparable and not serious.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Acetaminophen / therapeutic use
  • Adult
  • Aged
  • Analgesics / administration & dosage
  • Analgesics / adverse effects
  • Analgesics / therapeutic use*
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Benzoates / administration & dosage
  • Benzoates / adverse effects
  • Benzoates / therapeutic use
  • Clinical Trials as Topic
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pain / drug therapy
  • Phenylpropionates / administration & dosage
  • Phenylpropionates / adverse effects
  • Phenylpropionates / therapeutic use*

Substances

  • Analgesics
  • Anti-Inflammatory Agents
  • Benzoates
  • Phenylpropionates
  • Acetaminophen